These findings suggest that MEOX1 may serve as a potential biomarker for ovarian cancer LNM diagnosis and treatment.473 In gastric cancer, RPRD1B promotes fatty acid uptake and synthesis, as well as LNM through activating the c-Jun/c-Fos/SREBP1 axis. This evidence concerns the gene MEOX1 and ovarian cancer.